Although urinary EGFR could serve as a promising prognostic biomarker candidate for bladder cancer, it was identified as a low abundance urinary protein (1 unique peptide and <10 spectrums) and in practice was hard to measure by ELISA (data not shown). The gene discussed is EGFR; the disease is urinary bladder carcinoma.